Total Payments
$12,023
2024 Payments
$1,159
Companies
60
Transactions
466
Medicare Patients
2,975
Medicare Billing
$226,836
Payment Breakdown by Category
Food & Beverage$11,982 (99.7%)
Education$41.32 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,982 | 462 | 99.7% |
| Education | $41.32 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,470 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,438 | 53 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $776.16 | 30 | $0 (2024) |
| Amgen Inc. | $755.20 | 25 | $0 (2024) |
| Bausch Health US, LLC | $658.42 | 33 | $0 (2024) |
| Allergan, Inc. | $564.47 | 18 | $0 (2020) |
| GlaxoSmithKline, LLC. | $560.28 | 18 | $0 (2024) |
| PFIZER INC. | $526.57 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $507.02 | 21 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $495.93 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,159 | 49 | Amgen Inc. ($143.93) |
| 2023 | $1,432 | 47 | Regeneron Healthcare Solutions, Inc. ($188.76) |
| 2022 | $1,121 | 41 | ABBVIE INC. ($278.58) |
| 2021 | $1,077 | 53 | AbbVie Inc. ($287.02) |
| 2020 | $1,493 | 73 | PFIZER INC. ($183.06) |
| 2019 | $1,944 | 74 | AstraZeneca Pharmaceuticals LP ($451.71) |
| 2018 | $1,926 | 66 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($241.58) |
| 2017 | $1,871 | 63 | AstraZeneca Pharmaceuticals LP ($298.60) |
All Payment Transactions
466 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Obesity | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Neurology | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 717 | 1,139 | $101,713 | $56,849 |
| 2022 | 17 | 798 | 1,214 | $114,212 | $64,529 |
| 2021 | 13 | 633 | 1,082 | $91,115 | $52,555 |
| 2020 | 18 | 827 | 1,383 | $101,587 | $52,904 |
Total Patients
2,975
Total Services
4,818
Medicare Billing
$226,836
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 324 | $36,936 | $21,718 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 104 | $16,224 | $10,309 | 63.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 102 | 103 | $9,291 | $7,803 | 84.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 94 | $14,100 | $6,231 | 44.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 104 | 105 | $3,776 | $3,507 | 92.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 34 | 34 | $4,359 | $1,866 | 42.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 20 | $4,000 | $1,836 | 45.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 82 | $2,952 | $885.21 | 30.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 18 | 21 | $1,701 | $852.61 | 50.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 56 | 61 | $4,880 | $683.64 | 14.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $510.00 | $499.80 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 83 | $830.00 | $283.03 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 33 | $330.00 | $277.20 | 84.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 46 | $1,104 | $48.92 | 4.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 12 | $720.00 | $47.49 | 6.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 296 | $33,744 | $19,894 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 111 | $17,316 | $11,527 | 66.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 75 | 92 | $11,818 | $6,587 | 55.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 88 | 88 | $7,398 | $6,182 | 83.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 85 | $12,750 | $5,123 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 94 | $3,384 | $3,111 | 91.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 44 | 54 | $4,382 | $2,276 | 51.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $2,160 | $1,973 | 91.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $3,850 | $1,849 | 48.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 19 | $3,800 | $1,647 | 43.3% |
About Dr. Mark Gerard, MD
Dr. Mark Gerard, MD is a Internal Medicine healthcare provider based in Burbank, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023036670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Gerard, MD has received a total of $12,023 in payments from pharmaceutical and medical device companies, with $1,159 received in 2024. These payments were reported across 466 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($11,982).
As a Medicare-enrolled provider, Gerard has provided services to 2,975 Medicare beneficiaries, totaling 4,818 services with total Medicare billing of $226,836. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Burbank, CA
- Active Since 07/18/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1023036670
Products in Payments
- FARXIGA (Drug) $855.74
- XIFAXAN (Drug) $696.21
- APLENZIN (Drug) $625.18
- UBRELVY (Drug) $418.58
- ENTRESTO (Drug) $390.43
- JARDIANCE (Drug) $385.66
- DUPIXENT (Biological) $285.95
- Synthroid (Drug) $285.15
- Androgel (Drug) $283.09
- Otezla (Drug) $251.02
- Vascepa (Drug) $247.82
- QULIPTA (Drug) $234.42
- VRAYLAR (Drug) $234.13
- TRADJENTA (Drug) $233.98
- SHINGRIX (Biological) $229.49
- Superion ISS (Device) $227.92
- SYNTHROID (Drug) $206.64
- NORTHERA (Drug) $188.76
- MYRBETRIQ (Drug) $183.83
- SYMBICORT (Drug) $177.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Burbank
Hakop Gevorkyan, Md, MD
Internal Medicine — Payments: $398,821
Internal Medicine $398,821
Dr. Kanwarpal Kahlon, M.d, M.D
Internal Medicine — Payments: $159,719
Internal Medicine $159,719
Dr. Teresa Sligh, M.d, M.D
Internal Medicine — Payments: $116,619
Internal Medicine $116,619
Dr. Ramtin Anousheh, Md, MD
Internal Medicine — Payments: $75,638
Internal Medicine $75,638
Dr. Roy Mukku, M.d, M.D
Internal Medicine — Payments: $24,733
Internal Medicine $24,733
Kyle Cheng, M.d, M.D
Internal Medicine — Payments: $17,129
Internal Medicine $17,129